Abstracts tagged "osteoporosis and trainee"

Abstract Number: 3059 • 2016 ACR/ARHP Annual Meeting
Impact of a Musculoskeletal Training Program on Residents’ Evaluation, Diagnosis, and Treatment of Osteoporosis
Michael J. Battistone¹, Richard Nelson², Junjie Ma^3,4, Karla L. Miller⁵, Phillip Lawrence^6,7, Joanne Lafleur⁸, Marissa Grotzke⁹, Andrea M. Barker¹ and Grant W. Cannon⁵, ¹Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ²Epidemiology, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ³Veterans Affairs Salt Lake City Health Care System and University of Utah College of Pharmacy, Salt Lake City, UT, ⁴University of Utah College of Pharmacy, Salt Lake City, UT, ⁵Internal Medicine, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT, ⁶Salt Lake City VA Medical Center and Roseman University of Health Sciences, Salt Lake City, UT, ⁷Roseman University of Health Sciences, Salt Lake City, UT, ⁸University of Utah Department of Pharmacotherapy and Salt Lake City VA Medical Center, Salt Lake City, UT, ⁹Division of Endocrinology, Veterans Affairs Salt Lake City Health Care System and University of Utah School of Medicine, Salt Lake City, UT
Background/Purpose: The Center of Excellence (COE) in Musculoskeletal (MSK) Care and Education was established at the Salt Lake City Veterans Affairs Medical Center (SLCVAMC) in…
Abstract Number: 2004 • 2014 ACR/ARHP Annual Meeting
Osteoporosis Screening and Fracture Risk Assessment Tool Usage Among House Staff
Jordan Brodsky¹, Meghan Greenfield² and Erin Patton³, ¹Medicine, Albert Einstein College of Medicine, Woodmere, NY, ²279 E 10th St, Beth Israel Medical Center, New York, NY, ³Rheumatology, Beth Israel Medical Center, New York, NY
Background/Purpose: Despite increased awareness of the magnitude and consequences of osteoporosis and the availability of recommendations for screening and treatment by multiple organizations, osteoporosis is…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].